IMS Health (IMS) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
IMS Health (IMS) Price Target Lifted to $33 at Piper Jaffray Post Q1
April 27, 2015 7:28 AM EDTPiper Jaffray analyst Peter Appert reiterated an Overweight rating and boosted his price target on IMS Health Holdings (NYSE: IMS) to $33.00 (from $31.00) following Q1 results which showed platform strength.
Appert commented, "Upside to F1Q revenue, EBITDA and EPS, despite incremental F/X... More
